Stay updated with breaking news from Embecta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Embecta (NASDAQ:EMBC – Get Rating) is one of 225 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its rivals? We will compare Embecta to related companies based on the strength of its earnings, dividends, analyst recommendations, valuation, institutional ownership, risk and profitability. Dividends Embecta pays an […]
Embecta Corp. (NASDAQ:EMBC – Get Rating)’s share price was up 6.8% during mid-day trading on Tuesday . The company traded as high as $28.69 and last traded at $28.67. Approximately 250,312 shares changed hands during mid-day trading, a decline of 61% from the average daily volume of 645,738 shares. The stock had previously closed at […]
Jupiter Asset Management Ltd. raised its holdings in Embecta Corp. (NASDAQ:EMBC – Get Rating) by 1.0% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 104,304 shares of the company’s stock after acquiring an additional 986 shares during the quarter. Jupiter Asset Management Ltd. owned […]
Embecta Corp. (NASDAQ:EMBC – Get Rating) saw a large decrease in short interest in the month of April. As of April 30th, there was short interest totalling 3,360,000 shares, a decrease of 9.4% from the April 15th total of 3,710,000 shares. Based on an average daily volume of 461,900 shares, the days-to-cover ratio is presently […]
Embecta Corp. (NASDAQ:EMBC – Get Rating) was the recipient of a large decrease in short interest in the month of April. As of April 30th, there was short interest totalling 3,360,000 shares, a decrease of 9.4% from the April 15th total of 3,710,000 shares. Based on an average trading volume of 461,900 shares, the short-interest […]